{"Title": "Neurological update: gliomas and other primary brain tumours in adults", "Year": 2018, "Source": "J. Neurol.", "Volume": "265", "Issue": 3, "Art.No": null, "PageStart": 717, "PageEnd": 727, "CitedBy": 14, "DOI": "10.1007/s00415-017-8652-3", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85032969930&origin=inward", "Abstract": "\u00a9 2017, The Author(s).The emerging understanding of molecular changes in a wide range of brain tumours has led to a significant shift in how these tumours are diagnosed, managed and treated. This article will provide a hands-on overview of the relevant biomarkers and their association with newly defined biological tumour entities.", "AuthorKeywords": ["Astrocytoma", "ATRX", "BRAF", "BRAF inhibitor", "EGFR", "Ependymoma", "Glioblastoma", "Histone", "IDH", "MGMT", "Mutation", "Oligodendroglioma", "Temozolomide", "TERT", "Tumour heterogeneity"], "IndexKeywords": ["Biomarkers, Tumor", "Brain Neoplasms", "Glioma", "Humans"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85032969930", "SubjectAreas": [["Neurology", "NEUR", "2808"], ["Neurology (clinical)", "MEDI", "2728"]], "AuthorData": {"7006643850": {"Name": "Brandner S.", "AuthorID": "7006643850", "AffiliationID": "60019953, 60022148", "AffiliationName": "Department of Neurodegeneration, Institute of Neurology, University College London"}, "54083212800": {"Name": "Jaunmuktane Z.", "AuthorID": "54083212800", "AffiliationID": "60019953, 60022148", "AffiliationName": "Department of Molecular Neuroscience, Institute of Neurology, University College London"}}}